Article info

Download PDFPDF
Can clinical benefits of modulators effectively ‘modulate’ adherence in people with CF?

Authors

  1. Correspondence to Dr Chelsea S Davis, Pediatrics, University of Washington, Seattle, WA 98105, USA; chelsea.davis{at}seattlechildrens.org
View Full Text

Citation

Davis CS, Cogen JD
Can clinical benefits of modulators effectively ‘modulate’ adherence in people with CF?

Publication history

  • Accepted March 24, 2021
  • First published April 16, 2021.
Online issue publication 
August 13, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.